Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
12 Nov 2015 FDA Approves Cobimetinib as Part of Combination Treatment for Advanced Melanoma Melanoma - Anticancer agents & Biologic therapy
11 Nov 2015 Immunosurveillance in Breast Cancer Breast cancer - Cancer Immunology and Immunotherapy
10 Nov 2015 Pembrolizumab Receives FDA Breakthrough Therapy Designation in Advanced Colorectal Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy
06 Nov 2015 European Medicines Agency’s Review Concludes Evidence Does Not Support That HPV Vaccines Cause Complex Regional Pain Syndrome and Postural Orthostatic Tachycardia Syndrome Epidemiology/Etiology/Cancer Prevention
05 Nov 2015 Patient-Derived Tumour Xenograft Models Encyclopedia Translational research
04 Nov 2015 FDA Approves Talimogene Laherparepvec for the Treatment of Melanoma Melanoma - Cancer Immunology and Immunotherapy
03 Nov 2015 FDA Approves Ipilimumab to Reduce the Risk of Melanoma Recurrence After Surgery Melanoma - Cancer Immunology and Immunotherapy
02 Nov 2015 EMA Recommends Approval of Ciambra, Pemetrexed Hospira and Pemetrexed Medac Lung and other thoracic tumours - Anticancer agents & Biologic therapy
30 Oct 2015 FDA Approves Liposomal Irinotecan for Advanced Pancreatic Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
29 Oct 2015 The International Consensus of Intrinsic Subtypes of Colorectal Cancer Genitourinary cancers - Translational research
28 Oct 2015 EMA Adopts a Positive Opinion Recommending Changes to the Terms of the Marketing Authorisation for Aprepitant Cancer in Special Situations - Palliative and supportive care
27 Oct 2015 FDA Approves Trabectedin for Certain Types of Advanced Soft Tissue Sarcoma Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Oct 2015 EMA Adopts a Positive Opinion Recommending to Extend Therapeutic Indications for Crizotinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Oct 2015 EMA Recommends Approval of First Oncolytic Immunotherapy Medicine Melanoma - Cancer Immunology and Immunotherapy
21 Oct 2015 Drug Repurposing in Oncology Bioethics, legal and economic issues - Anticancer agents & Biologic therapy